AU2003227026A1 - An infectious bursal disease virus variant - Google Patents

An infectious bursal disease virus variant

Info

Publication number
AU2003227026A1
AU2003227026A1 AU2003227026A AU2003227026A AU2003227026A1 AU 2003227026 A1 AU2003227026 A1 AU 2003227026A1 AU 2003227026 A AU2003227026 A AU 2003227026A AU 2003227026 A AU2003227026 A AU 2003227026A AU 2003227026 A1 AU2003227026 A1 AU 2003227026A1
Authority
AU
Australia
Prior art keywords
disease virus
bursal disease
infectious bursal
virus variant
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227026A
Inventor
Paul Guntram
Adriaan Antonius Wilhelmus Maria Van Loon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2003227026A1 publication Critical patent/AU2003227026A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU2003227026A 2002-03-01 2003-02-25 An infectious bursal disease virus variant Abandoned AU2003227026A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP02075881.9 2002-03-01
EP02075881 2002-03-01
EP02079827.8 2002-11-21
EP02079827 2002-11-21
PCT/EP2003/001905 WO2003074552A1 (en) 2002-03-01 2003-02-25 An infectious bursal disease virus variant

Publications (1)

Publication Number Publication Date
AU2003227026A1 true AU2003227026A1 (en) 2003-09-16

Family

ID=27790100

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227026A Abandoned AU2003227026A1 (en) 2002-03-01 2003-02-25 An infectious bursal disease virus variant

Country Status (4)

Country Link
EP (1) EP1483287A1 (en)
AU (1) AU2003227026A1 (en)
PL (1) PL209994B1 (en)
WO (1) WO2003074552A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689858B1 (en) * 2003-11-13 2013-05-15 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus
NZ549687A (en) * 2004-03-12 2008-08-29 Wyeth Corp Infectious bursal disease virus antigenic isolates and vaccines
ES2310062B1 (en) 2005-07-15 2009-11-13 Bionostra, S.L. PSEUDOVIRAL PARTICLES CHEMICAL EMPTY DERIVED FROM VIRUS CAUSING INFECTIOUS BURSITIS DISEASE (IBDV), PROCEDURE OF OBTAINING AND APPLICATIONS.
CN103232974B (en) * 2013-03-18 2014-09-03 江苏省农业科学院 Hybridoma cell strain secreting high-neutralization activity infectious bursal disease virus (IBDV) monoclonal antibody
CN109320594B (en) * 2018-11-13 2021-09-28 四川大学 Virus-like particle for avian infectious bronchitis and newcastle disease, preparation method and application
CN112501129B (en) * 2020-12-14 2022-12-02 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） anti-IBDV VP2 protein monoclonal antibody combination and application thereof in identifying and detecting IBDV
CN112500458B (en) * 2020-12-15 2022-12-16 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） Novel variant subunit vaccine of chicken infectious bursal disease virus, preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
EP1170302B1 (en) * 2000-07-07 2006-06-21 Intervet International BV Infectious bursal disease virus vaccines

Also Published As

Publication number Publication date
PL209994B1 (en) 2011-11-30
PL372453A1 (en) 2005-07-25
WO2003074552A1 (en) 2003-09-12
EP1483287A1 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
AU2002367748A1 (en) Infectious disease microarray
IL174403A0 (en) Macrocyclic peptides active against the hepatitis c virus
PL371007A1 (en) Macrocyclic peptides active against the hepatitis c virus
AU2002210450A1 (en) Maintaining virus detection software
AU2002332902A1 (en) Retractable hyposermic syringe
AU2003215806A1 (en) Disinfectant with activity against hepatitis b virus
AU2003201458A1 (en) Infectious disease surveillance system
AU2003206862A1 (en) Hepatitis b vaccines
AU6029000A (en) Mosaic infectious bursal disease virus vaccines
AU2003301850A1 (en) Hiv vaccine
AU2003294757A1 (en) Formulations useful against hepatitis c virus infections
EP1399481A4 (en) Recombinant antibodies against infectious bursal disease virus (ibdv)
AU2002367215A1 (en) Dealing with a computer virus which self-propagates by email
AU2003227026A1 (en) An infectious bursal disease virus variant
AU2002310654A1 (en) Bursal disease virus-like particles
AU2000252449A1 (en) Recombinant vaccines against infectious bursal disease virus
AU5098700A (en) Dna vaccine for protecting an avian against infectious bursal disease virus
AU2003214430A1 (en) Acoustic emission
AU2003237701A1 (en) Vaccines
AU2003256404A1 (en) Hepatitis c virus assays
AU2003273035A1 (en) Gene vaccine
AU2002236065A1 (en) Papillomavirus vaccines
AU4957800A (en) Vaccine against isa virus
AU2003225479A1 (en) Reporter-selectable hepatitis c virus replicon
AU1674200A (en) Dna vaccine against infectious bursal disease virus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase